Tirzepatide Linked to Lower Glaucoma Risk in Type 2 Diabetes Compared to Other Weight Loss Drugs: Study Medha Baranwal17 Dec 2025 8:45 PM ISTUSA: A large retrospective cohort study found that the dual GIP/GLP-1 receptor agonist tirzepatide was associated with a significantly reduced risk of...
Tirzepatide Shows Lower Mortality and Better Cardiorenal Outcomes than Semaglutide in Coronary Artery Disease and Obesity: AHJ Study, December 2025 Dr. Bhumika Maikhuri15 Dec 2025 11:15 AM ISTIn patients with coronary artery disease (CAD) and obesity, tirzepatide was associated with lower mortality and reduced cardiovascular and renal...
Medical Bulletin 04/December/2025 Anshika Mishra4 Dec 2025 3:00 PM ISTHere are the top medical news for today:WHO releases first global guideline on GLP-1 therapies for obesity treatment Obesity now affects over 1...
WHO releases first global guideline on GLP-1 therapies for obesity treatment Anshika Mishra4 Dec 2025 8:00 AM ISTObesity now affects over 1 billion people worldwide, driving millions of deaths and trillions in costs-yet new WHO guidance offers hope through GLP-1...
Stopping Tirzepatide may lead to Weight Regain and Backslide Heart-Metabolic Gains: JAMA Medha Baranwal2 Dec 2025 8:30 PM ISTUSA: Researchers have found in a new study that stopping tirzepatide (Zepbound) often leads to weight regain, along with the loss of earlier health...
Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial Deeksha Bhandari2 Dec 2025 10:57 AM ISTThe SURMOUNT-1 trial evaluated Tirzepatide a dual GIP/GLP1 agonist, in individuals with overweight (BMI more than or equal to 27 with a comorbidity)...
Tirzepatide may only temporarily suppress brain activity involved in "food noise", suggests study Dr. Kamal Kant Kohli24 Nov 2025 9:00 PM ISTA rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, ...
Explainer Video: Acknowledge- Assisting Patients Through Challenges in Their Diabetes Care Journey Deeksha Bhandari22 Nov 2025 12:01 PM IST Weight management is an important but challenging part of type 2 diabetes care, especially for people with overweight or obesity. Even...
Tirzepatide Linked to Higher Risk of Osteoporosis and Fracture compared to other GLP-1 receptor agonists: Study Dr Riya Dave18 Nov 2025 8:30 PM ISTResearchers have found in a new large real-world cohort study that starting tirzepatide was associated with a significantly increased risk of...
Semaglutide, tirzepatide, and dulaglutide have similar Gl safety profiles in clinical settings, suggests study Dr. Kamal Kant Kohli18 Nov 2025 9:15 AM ISTA new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and tirzepatide in patients...
Obesity drugs improve heart health: Study shows additional benefits of semaglutide and tirzepatide Dr. Kamal Kant Kohli13 Nov 2025 8:15 PM ISTInjectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical...
Medical Bulletin 12/November/2025 Dr. Bhumika Maikhuri12 Nov 2025 4:00 PM ISTHere are the top medical news for the day:Targeted Vitamin D Therapy Cuts Risk of Repeat Heart Attack by Half: Study Finds A new study has reported...
